Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

749 Press Releases
DateTitleCompany
14 Dec 15 Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Pfizer ,
Published by
PharmiWeb.com
14 Dec 15 Pfizer Declares First-Quarter 2016 Dividend Pfizer ,
Published by
PharmiWeb.com
14 Dec 15 Pfizer Declares First-Quarter 2016 Dividend Pfizer Inc.,
Published by
Business Wire
11 Dec 15 AMPLIFY Post-Hoc Early Time Course Analysis Evaluated Recurrent Venous Thromboembolism (VTE), VTE-Related Death and Major Bleeding in Deep Vein Thrombosis and Pulmonary Embolism Patients Treated with Eliquis (apixaban) or Conventional Therapy Pfizer ,
Published by
PharmiWeb.com
11 Dec 15 Pfizer Announces FDA Acceptance of IBRANCE® (palbociclib) Supplemental New Drug Application with Priority Review in HR+, HER2- Metastatic Breast Cancer Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 New Phase III Study of Nintedanib in People with Systemic Sclerosis and Lung Fibrosis Launched Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Pfizer Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for XALKORI® (crizotinib) for the Treatment of Patients with ROS1-Positive Metastatic Non-Small Cell Lung Cancer Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015 Pfizer ,
Published by
PharmiWeb.com
10 Dec 15 Pfizer Receives U.S. FDA Approval of New QuilliChew ERâ„¢ (methylphenidate hydrochloride) extended-release chewable tablets CII Pfizer ,
Published by
PharmiWeb.com
09 Dec 15 Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers Pfizer,
Published by
Business Wire
08 Dec 15 Pfizer Awards More Than $4 Million in Grants to Further Clinical Research in Advanced Breast Cancer for 2015 Pfizer Inc.,
Published by
Business Wire
04 Dec 15 Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Pfizer ,
Published by
PharmiWeb.com
02 Dec 15 Pfizer Receives European Approval to Expand Use of Lung Cancer Treatment XALKORI® (crizotinib) Pfizer
01 Dec 15 Pfizer Canada Confirms that Sufficient EpiPen® Auto-Injector Stock Is Now Available to Meet Needs of Canadian Patients Pfizer ,
Published by
PharmiWeb.com
27 Nov 15 Pfizer Canada confirms that Sufficient EpiPen® Auto-Injector Stock Is Now Available to Meet Needs of Canadian Patients Pfizer Canada Inc.,
Published by
PR Newswire
25 Nov 15 Pfizer Receives European Approval to Expand Use of XALKORI® (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer Pfizer ,
Published by
PharmiWeb.com
25 Nov 15 Pfizer Reports Top-Line Results from a Phase 3 Study of LYRICA® (pregabalin) Capsules CV in Adults with Post-Traumatic Peripheral Neuropathic Pain Pfizer Inc.,
Published by
Business Wire
25 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products Pfizer Inc.,
Published by
Business Wire
04 Nov 15 Merck and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer Pfizer,
Published by
Business Wire
05 Nov 15 Pfizer Expands its Patient Assistance Program, Doubling the Income Eligibility Limit to Benefit Even More Patients Taking Pfizer Medicines  Pfizer Inc.,
Published by
Business Wire
31 Oct 15 Pfizer Inc. Announcement under Rule 2.10 of the Irish Takeover Rules – Relevant Securities in Issue Pfizer Inc.,
Published by
Business Wire
18 Nov 15 Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI® (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Pfizer Inc.,
Published by
Business Wire
17 Nov 15 Global Partners Announce Donation of 500 Millionth Dose of Azithromycin, Marking Exceptional Progress to Help Alleviate the Suffering from Trachoma Pfizer ,
Published by
PharmiWeb.com
18 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma Pfizer Inc.,
Published by
Business Wire
04 Nov 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer Pfizer Inc.,
Published by
Business Wire
29 Oct 15 Pfizer Announces Collaboration with GSK on Next-Generation Design of Portable, Continuous, Miniature and Modular (PCMM) Oral Solid Dose Development and Manufacturing Units Pfizer Inc.,
Published by
Business Wire
14 Oct 15 Pfizer Receives Complete Response Letter from FDA for Oral XELJANZ® (tofacitinib citrate) Supplemental New Drug Application for Moderate to Severe Chronic Plaque Psoriasis Pfizer Inc.,
Published by
Business Wire
07 Oct 15 Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma Pfizer,
Published by
Business Wire
09 Oct 15 Pfizer’s Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap) Vaccines in Adolescents Pfizer Inc.,
Published by
Business Wire
29 Oct 15 Pfizer Announcement Regarding Allergan plc Pfizer,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.